Opportunities to play animal-health market growth may be limited: Barron’s

A surge in pet sales is leading growth overall in the $36B global animal-health market, with livestock accounting for two-thirds of the market, while pets make up the remainder, Lawrence Strauss writes in this week’s edition of Barron’s. For investors wanting to play this growth directly, the opportunities are limited and pricey, he contends. Of the four large animal-health entities – Zoetis (ZTS), Elanco Animal Health (ELAN), Merck (MRK) and Bayer (BAYRY) -, only Zoetis and Elanco are pure plays, having been spun off, the author notes

https://thefly.com/landingPageNews.php?id=2886420